Figure 3From: Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis Cost-effectiveness acceptability curves based on Monte Carlo simulations of single treatments and no treatment (data on effectiveness based on head-to-head-trials against CCB in addition to CCB vs placebo) -70 year old men (for simplicity; only curves with probability higher than 4% included in the graph).Back to article page